Inscription Capital, LLC Summit Therapeutics Inc. Transaction History

Inscription Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$1.38 - $5.41 $6,899 - $27,050	-5,000 Reduced 29.41%	12,000 $21,000
Q3 2021 Nov 09, 2021	BUY	$4.83 - $8.27 $82,110 - $140,590	17,000 New	17,000 $85,000
Q2 2021 Aug 13, 2021	SELL	$5.15 - $8.46 $87,550 - $143,820	-17,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.08 - $3.8 $52,360 - $64,600	17,000 New	17,000 $58,000

107

41.3M

103K

29.9K

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $1.46B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Inscription Capital, LLC with notifications on news.